Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Exploit Technologies
Singapore, Singapore
- Ownership
- Private
- Development stage
- Other
01
Overview
Exploit Technologies Pte. Ltd. (ETPL) is the technology transfer and commercialization arm of Singapore’s Agency for Science, Technology and Research (ASTAR). It identifies promising intellectual property from ASTAR’s research institutes—spanning biomedical sciences and other fields—and facilitates their translation into marketable products through licensing deals and spin-offs with industry partners. ETPL manages thousands of patents and has enabled hundreds of licenses generating significant commercial revenue for Singapore’s innovation ecosystem.
- Industry
- Consulting
02
Partnerships
Numerous partnerships with industry leaders to commercialize A*STAR technologies
Beyond the preview
Go deeper on Exploit Technologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Exploit Technologies.